 |
Open for inclusion |
Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible TumourCancer type: Multiple diagnosis Phase: I/II Principal Investigator: Brunsvig Paal Country: NO Keywords: Norway, Oslo University Hospital Status: Inclusion completed Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT01058616?term=C08-315-01&rank=1 |